DD
44
2
CAT
47
3
EIX
61
8
MPC
28
3
HRB
40
3
AEE
51
3
PNW
55
3
MAR
57
3
DRI
74
5
HAS
29
3
NTAP
58
3
UNP
38
5
CAG
34
3
HBAN
47
7
CAH
44
7
SYF
78
7
NRG
32
5
EA
41
3
PWR
63
3
UAL
73
3
DD
44
2
CAT
47
3
EIX
61
8
MPC
28
3
HRB
40
3
AEE
51
3
PNW
55
3
MAR
57
3
DRI
74
5
HAS
29
3
NTAP
58
3
UNP
38
5
CAG
34
3
HBAN
47
7
CAH
44
7
SYF
78
7
NRG
32
5
EA
41
3
PWR
63
3
UAL
73
3
Financhill
Back

Skye Bioscience 10K Form

Sell
12

SKYE
Skye Bioscience

Last Price:
$2.70
Seasonality Move:
59.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SKYE News And Ratings

See the #1 stock for the next 7 days that we like better than SKYE

SKYE Financial Statistics

Sales & Book Value

Annual Sales: $339.9K
Cash Flow: $-6.8M
Price / Cash Flow: 0
Annual Sales: $2.50
Price / Book: 1.09

Profitability

EPS (TTM): -0.83790
Net Income (TTM): $-21.2M
Gross Margin: $208.6K
Return on Equity: 0%
Return on Assets: 0%

Skye Bioscience Earnings Forecast

Key Skye Bioscience Financial Ratios

  • The Gross Profit Margin over the past 2 years for SKYE is 61.36%.
  • The Selling, General & Administrative Expenses for SKYE have been equal to 43.69% of Gross Profit Margin.
  • The Interest Expense is -2.38% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Skye Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SKYE
Website: skyebioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SKYE Technical Analysis vs Fundamental Analysis

Sell
12
Skye Bioscience (SKYE) is a Sell

Is Skye Bioscience a Buy or a Sell?

  • Skye Bioscience stock is rated a Sell
    The current Skye Bioscience [SKYE] share price is $2.72. The Score for SKYE is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.